Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.10/557
Título: Tocilizumab: is there life beyond anti-TNF blockade?
Autor: Alves, J
Marinho, A
Serra, M
Palavras-chave: Rheumatoid arthritis
Arterite reumatóide
Tocilizumab
Data: 2011
Editora: Medicom International
Citação: Int J Clin Pract. 2011 Apr;65(4):508-13
Resumo: Anti-TNF-α therapy has become the most effective biological treatment for rheumatoid arthritis. Despite having changed the prognosis of the disease establishing new targets for treatment strategy, there are several aspects that still remain unmatched. About 30% of the patients with rheumatoid arthritis have a less than satisfactory response to anti-TNF therapy, which has led the way for the pursuit of new targets and approaches to treatment. IL-6 is one of these alternative targets and data from the more recent clinical trials involving tocilizumab (an anti-IL-6 soluble receptor antibody) suggest advantages in relation to some clinical aspects which are not addressed by anti-TNF-α treatment.
URI: http://hdl.handle.net/10400.10/557
ISSN: 1368-5031
Aparece nas colecções:MED - Artigos

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Int J Clin Pract. 2011 Apr, 65(4)508-13.pdf92,7 kBAdobe PDFVer/Abrir    Acesso Restrito. Solicitar cópia ao autor!


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.